Search Results - "Lichtenstein, Maya"

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study by Huang, Xuemei, Alonso, Alvaro, Guo, Xuguang, Umbach, David M., Lichtenstein, Maya L., Ballantyne, Christie M., Mailman, Richard B., Mosley, Thomas H., Chen, Honglei

“…Previous findings on the association of statins, plasma lipids, and Parkinson's disease (PD) are confounded by the fact that statins also affect lipid…”
Get full text

Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression: A Two-Step Pilot Study by Lichtenstein, Maya L., Stewart, Peter V., Kirchner, H. Lester, Finney, Glen, Feldman, Howard H.

“…Behavioral-variant frontotemporal dementia (bvFTD) is challenging to recognize, and often misdiagnosed as depression (DEP). Evidence suggests changes in social…”
Get full text

Validation and extension of the quick dementia rating system (QDRS) by Stewart, Peter V., Tapscott, Brian E., Davis, Beate, Boscarino, Joseph J., Sanders, Keshia, Rodgers, Sarajane E., Lichtenstein, Maya L.

“…Informant report dementia severity staging measures, such as the Quick Dementia Rating System (QDRS) offer clinicians useful diagnostic and staging…”
Get full text

Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis by Farrell, Martilias, Dietterich, Tyler E, Harner, Matthew K, Bruno, Lisa M, Filmyer, Dawn M, Shaughnessy, Rita A, Lichtenstein, Maya L, Britt, Allison M, Biondi, Tamara F, Crowley, James J, Lázaro-Muñoz, Gabriel, Forsingdal, Annika E, Nielsen, Jacob, Didriksen, Michael, Berg, Jonathan S, Wen, Jia, Szatkiewicz, Jin, Mary Xavier, Rose, Sullivan, Patrick F, Josiassen, Richard C

“…Abstract Background It remains unknown why ~30% of patients with psychotic disorders fail to respond to treatment. Previous genomic investigations of…”
Get full text

Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome by Harner, Matthew K., Lichtenstein, Maya, Farrell, Martilias, Dietterich, Tyler E., Filmyer, Dawn M., Bruno, Lisa M., Biondi, Tamara F., Crowley, James J., Lázaro-Muñoz, Gabriel, Stowe, Robert, Shaughnessy, Rita A., Berg, Jonathan S., Szatkiewicz, Jin, Sullivan, Patrick F., Josiassen, Richard C.

“…The 3q29 deletion is a rare copy number variant associated with neurodevelopmental and psychiatric disorders, including a >40-fold increased risk for…”
Get full text

Neurobehavioral characterization of adult-onset alexander's disease: A family study by Lichtenstein, Maya L, Dwosh, Emily, Roychowdhury, Anupama, Feldman, Howard

Get full text

16-Year Survival of the Canadian Collaborative Cohort of Related Dementias by Lichtenstein, Maya L, Fallah, Nader, Mudge, Benita, Hsiung, Ging-Yuek R, Foti, Dean, Beattie, B Lynn, Feldman, Howard H

“…Background Survival estimates are integral to care for patients diagnosed with dementia. Few Canadian studies have carried out long-term follow-up of…”
Get more information

Neurobehavioral characterization of adult-onset Alexander disease: A family study by Lichtenstein, Maya L, Dwosh, Emily, Roy Chowdhury, Anupama, Farrer, Matthew J, McKenzie, Marna B, Guella, Ilaria, Evans, Daniel M, Nygaard, Haakon B, Shewchuk, Jason R, Hayden, Sherri, Barton, Jason J S, Feldman, Howard H

Get full text

Alcoholic Wernicke’s Encephalopathy with Cranial Nerve XII Involvement on MRI (P5.040) by Lichtenstein, Maya, Nguyen, Dan

“…Abstract only…”
Get full text

ENROLLING PARTICIPANTS WITH DEMENTIA IN A RURAL SETTING: GEISINGER RECRUITMENT STRATEGIES FOR D-CARE by Lichtenstein, Maya, Borek, Pamela, Ladd, Ilene

“…Geisinger Health System serves a large, geographically stable population in central and northeast Pennsylvania and was chosen to participate in D-CARE due to…”
Get full text

Population prevalence of autosomal dominant Alzheimer’s disease: A systematic review: Epidemiology / Prevalence, incidence, and outcomes of MCI and dementia by Potter, Richard R, Long, Alexandra P, Lichtenstein, Maya L

Get full text

Population prevalence of autosomal dominant Alzheimer’s disease: A systematic review by Potter, Richard R, Long, Alexandra P, Lichtenstein, Maya L

“…Background Alzheimer's disease is the leading cause of dementia, accounting for >50% of cases. Autosomal dominant Alzheimer's Disease (ADAD) is estimated to…”
Get full text

Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression: A Two-Step Pilot Study by Lichtenstein, Maya L., Stewart, Peter V., Kirchner, H. Lester, Finney, Glen, Feldman, Howard H.

“…Behavioral-variant frontotemporal dementia (bvFTD) is challenging to recognize, and often misdiagnosed as depression (DEP). Evidence suggests changes in social…”
Get full text

Passive Digital Markers for Alzheimer’s Disease and Related Dementia Predict Mild Cognitive Impairment by Abbas, Mostafa, Morland, Thomas, Lichtenstein, Maya, Milad, Zina Ben, Finney, Glen, Boustani, Malaz, El‐Manzalawy, Yasser

“…Background Alzheimer’s Disease and Related Dementia (ADRD) typically progresses through three clinical stages: Normal Cognition (NC), Mild Cognitive Impairment…”
Get full text

Survival in Dementia and Cognitive Impairment Not Dementia: 16 Year Follow Up from the ACCORD Study (P1.102) by Lichtenstein, Maya, Fallah, Nader, Feldman, Howard

“…Abstract only…”
Get full text

T98. CHALLENGES AND ETHICAL CONSIDERATIONS IN RECRUITING PATIENTS WITH ``EXTREME'' TREATMENT-RESISTANT SCHIZOPHRENIA FOR GENOMIC INVESTIGATIONS: THE PASH STUDY by Xavier, Rose Mary, Dietterich, Tyler, Harner, Matthew, Filmyer, Dawn, Bruno, Lisa, Lichtenstein, Maya, Lazaro-Munoz, Gabriel, Farrell, Martilias, Shaughnessy, Rita, Sullivan, Patrick, Josiassen, Richard

“…Many patients (∼30%) with schizophrenia experience little or no benefit from antipsychotic medications (“treatment-resistant schizophrenia” - TRS). Extreme…”
Get full text

Psychosis in a Middle-aged Woman: A Case of Presenilin-1 p.Gly206Ala Alzheimer Disease by Venditto, Joseph Gerald, Bender, Evin, Lichtenstein, Maya L.

Get full text

P2‐168: IMMUNOHISTOCHEMISTRY OF O‐LINKED N‐ACETYLGLUCOSAMINE TRANSFERASE (OGT) AND AUTOPHAGY MARKER LC3B IN ALZHEIMER'S DISEASE by Lichtenstein, Maya L., Fallah, Nader, Feldman, Howard H., Mackenzie, Ian R., Vocadlo, David

Get full text

IMMUNOHISTOCHEMISTRY OF O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE (OGT) AND AUTOPHAGY MARKER LC3B IN ALZHEIMER’S DISEASE by Lichtenstein, Maya L., Fallah, Nader, Feldman, Howard H., Mackenzie, Ian R., Vocadlo, David

Get full text

Treatment-Resistant Schizophrenia and Early-Onset Dementia: A Case Report of the 3q29 Deletion Syndrome by Harner, Matthew K, Lichtenstein, Maya, Farrell, Martilias, Dietterich, Tyler E, Filmyer, Dawn M, Bruno, Lisa M, Biondi, Tamara F, Crowley, James J, Lázaro-Muñoz, Gabriel, Stowe, Robert, Shaughnessy, Rita A, Berg, Jonathan S, Szatkiewicz, Jin, Sullivan, Patrick F, Josiassen, Richard C

Get full text